These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29132930)

  • 1. A novel algorithm increases the delivery of effective cardiac resynchronization therapy during atrial fibrillation: The CRTee randomized crossover trial.
    Plummer CJ; Frank CM; Bári Z; Al Hebaishi YS; Klepfer RN; Stadler RW; Ghosh S; Liu S; Mittal S
    Heart Rhythm; 2018 Mar; 15(3):369-375. PubMed ID: 29132930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients: Results of the Adaptive Cardiac Resynchronization Therapy Trial.
    Birnie D; Hudnall H; Lemke B; Aonuma K; Lee KL; Gasparini M; Gorcsan J; Cerkvenik J; Martin DO
    Heart Rhythm; 2017 Dec; 14(12):1820-1825. PubMed ID: 28893549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic ventricular overdrive stimulation in atrial fibrillation: effects on ventricular rate irregularity, ventricular pacing, and fusion beats.
    Nölker G; Gutleben KJ; Asbach S; Ritscher G; Marschang H; Sinha AM; Boileau P; Benser ME; Hallier B; Hümmer A; Brachmann J
    Europace; 2011 Dec; 13(12):1688-94. PubMed ID: 21784744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of cardiac resynchronization therapy in patients with intermittent atrial fibrillation or atrial flutter in the COMPANION trial.
    Kalscheur MM; Saxon LA; Lee BK; Steinberg JS; Mei C; Buhr KA; DeMets DL; Bristow MR; Singh SN
    Heart Rhythm; 2017 Jun; 14(6):858-865. PubMed ID: 28323173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.
    Boriani G; Gasparini M; Landolina M; Lunati M; Proclemer A; Lonardi G; Iacopino S; Rahue W; Biffi M; DiStefano P; Grammatico A; Santini M;
    Eur J Heart Fail; 2011 Aug; 13(8):868-76. PubMed ID: 21558331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).
    Gasparini M; Leclercq C; Lunati M; Landolina M; Auricchio A; Santini M; Boriani G; Lamp B; Proclemer A; Curnis A; Klersy C; Leyva F
    JACC Heart Fail; 2013 Dec; 1(6):500-7. PubMed ID: 24622002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case selection for cardiac resynchronization in atrial fibrillation.
    Cleland JG; Keshavarzi F; Pellicori P; Dicken B
    Heart Fail Clin; 2013 Oct; 9(4):461-74, ix. PubMed ID: 24054479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of ventricular interval during atrial fibrillation by atrioventricular node vagal stimulation: chronic clinical atrioventricular-nodal stimulation download study.
    Bianchi S; Rossi P; Schauerte P; Elvan A; Blomström-Lundqvist C; Kornet L; Gal P; Mörtsell D; Wouters G; Gemein C
    Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):562-8. PubMed ID: 25878323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes After Ablation of the AV Junction in Patients With Atrial Fibrillation: Impact of Cardiac Resynchronization Therapy.
    Mittal S; Musat DL; Hoskins MH; Prillinger JB; Roberts GJ; Nabutovsky Y; Merchant FM
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29180458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes with synchronized left ventricular pacing: analysis of the adaptive CRT trial.
    Birnie D; Lemke B; Aonuma K; Krum H; Lee KL; Gasparini M; Starling RC; Milasinovic G; Gorcsan J; Houmsse M; Abeyratne A; Sambelashvili A; Martin DO
    Heart Rhythm; 2013 Sep; 10(9):1368-74. PubMed ID: 23851059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world behavior of CRT pacing using the AdaptivCRT algorithm on patient outcomes: Effect on mortality and atrial fibrillation incidence.
    Singh JP; Cha YM; Lunati M; Chung ES; Li S; Smeets P; O'Donnell D
    J Cardiovasc Electrophysiol; 2020 Apr; 31(4):825-833. PubMed ID: 32009263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasons for loss of cardiac resynchronization therapy pacing: insights from 32 844 patients.
    Cheng A; Landman SR; Stadler RW
    Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):884-8. PubMed ID: 22923341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
    Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
    Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular-only pacing in heart failure patients with normal atrioventricular conduction improves global function and left ventricular regional mechanics compared with biventricular pacing: an adaptive cardiac resynchronization therapy sub-study.
    Burns KV; Gage RM; Curtin AE; Gorcsan J; Bank AJ
    Eur J Heart Fail; 2017 Oct; 19(10):1335-1343. PubMed ID: 28653458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuously adjusting CRT therapy: clinical impact of adaptive cardiac resynchronization therapy.
    Houmsse M; Abraham WT
    Expert Rev Cardiovasc Ther; 2014 May; 12(5):541-8. PubMed ID: 24678730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response.
    Hwang JK; Gwag HB; Park KM; On YK; Kim JS; Park SJ
    PLoS One; 2019; 14(1):e0210603. PubMed ID: 30633768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of atrial fibrillation on improvement of functional mitral regurgitation in cardiac resynchronization therapy.
    van der Bijl P; Vo NM; Leung M; Ajmone Marsan N; Delgado V; Stone GW; Bax JJ
    Heart Rhythm; 2018 Dec; 15(12):1816-1822. PubMed ID: 30017815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm.
    Jędrzejczyk-Patej E; Lenarczyk R; Pruszkowska P; Kowalski O; Mazurek M; Sokal A; Boidol J; Woźniak A; Pluta S; Szulik M; Liberska A; Kalarus Z
    Cardiol J; 2014; 21(3):309-15. PubMed ID: 23990182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation incidence and impact of biventricular pacing on long-term outcome in patients with heart failure treated with cardiac resynchronization therapy.
    Jacobsson J; Reitan C; Carlson J; Borgquist R; Platonov PG
    BMC Cardiovasc Disord; 2019 Aug; 19(1):195. PubMed ID: 31409276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.